Global Testosterone Replacement Therapy Market Growth 2025-2031

Publication ID:

LPI07251697

Publication Date:

July 2, 2025

Pages:

111

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Testosterone Replacement Therapy market size is predicted to grow from US$ 1324 million in 2025 to US$ 1020 million in 2031; it is expected to grow at a CAGR of -4.3% from 2025 to 2031.
Testosterone replacement therapy (TRT) is a class of hormone replacement therapy in which androgens, often testosterone, are replaced. Testosterone replacement therapy (TRT) is an FDA-approved medical treatment for men of any age who have low testosterone, a hormone necessary for male sexual development.
Global Testosterone Replacement Therapy key players include AbbVie, Endo International, Eli lilly, Pfizer, Actavis (Allergan) etc. Global top five manufacturers hold a share over 70%. North America is the largest market, with a share over 80%, followed by Europe and Asia (Ex. China) , both have a share over 10% percent.
In terms of product, Gels is the largest segment, with a share over 60%. And in terms of application, the largest application is Clinics, followed by Hospitals.
The 鈥淭estosterone Replacement Therapy Industry Forecast鈥� looks at past sales and reviews total world Testosterone Replacement Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Testosterone Replacement Therapy sales for 2025 through 2031. With Testosterone Replacement Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Testosterone Replacement Therapy industry.
This Insight Report provides a comprehensive analysis of the global Testosterone Replacement Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Testosterone Replacement Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Testosterone Replacement Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Testosterone Replacement Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Testosterone Replacement Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Testosterone Replacement Therapy market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Gels
Injections
Patches
Other
Segmentation by Application:
Hospitals
Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
AbbVie
Endo International
Eli lilly
Pfizer
Actavis (Allergan)
Bayer
Novartis
Teva
Mylan
Upsher-Smith
Ferring Pharmaceuticals
Kyowa Kirin
Acerus Pharmaceuticals
Key Questions Addressed in this Report
What is the 10-year outlook for the global Testosterone Replacement Therapy market?
What factors are driving Testosterone Replacement Therapy market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Testosterone Replacement Therapy market opportunities vary by end market size?
How does Testosterone Replacement Therapy break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Testosterone Replacement Therapy Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Testosterone Replacement Therapy by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Testosterone Replacement Therapy by Country/Region, 2020, 2024 & 2031
2.2 Testosterone Replacement Therapy Segment by Type
2.2.1 Gels
2.2.2 Injections
2.2.3 Patches
2.2.4 Other
2.3 Testosterone Replacement Therapy Sales by Type
2.3.1 Global Testosterone Replacement Therapy Sales Market Share by Type (2020-2025)
2.3.2 Global Testosterone Replacement Therapy Revenue and Market Share by Type (2020-2025)
2.3.3 Global Testosterone Replacement Therapy Sale Price by Type (2020-2025)
2.4 Testosterone Replacement Therapy Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Testosterone Replacement Therapy Sales by Application
2.5.1 Global Testosterone Replacement Therapy Sale Market Share by Application (2020-2025)
2.5.2 Global Testosterone Replacement Therapy Revenue and Market Share by Application (2020-2025)
2.5.3 Global Testosterone Replacement Therapy Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Testosterone Replacement Therapy Breakdown Data by Company
3.1.1 Global Testosterone Replacement Therapy Annual Sales by Company (2020-2025)
3.1.2 Global Testosterone Replacement Therapy Sales Market Share by Company (2020-2025)
3.2 Global Testosterone Replacement Therapy Annual Revenue by Company (2020-2025)
3.2.1 Global Testosterone Replacement Therapy Revenue by Company (2020-2025)
3.2.2 Global Testosterone Replacement Therapy Revenue Market Share by Company (2020-2025)
3.3 Global Testosterone Replacement Therapy Sale Price by Company
3.4 Key Manufacturers Testosterone Replacement Therapy Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Testosterone Replacement Therapy Product Location Distribution
3.4.2 Players Testosterone Replacement Therapy Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Testosterone Replacement Therapy by Geographic Region
4.1 World Historic Testosterone Replacement Therapy Market Size by Geographic Region (2020-2025)
4.1.1 Global Testosterone Replacement Therapy Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Testosterone Replacement Therapy Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Testosterone Replacement Therapy Market Size by Country/Region (2020-2025)
4.2.1 Global Testosterone Replacement Therapy Annual Sales by Country/Region (2020-2025)
4.2.2 Global Testosterone Replacement Therapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas Testosterone Replacement Therapy Sales Growth
4.4 APAC Testosterone Replacement Therapy Sales Growth
4.5 Europe Testosterone Replacement Therapy Sales Growth
4.6 Middle East & Africa Testosterone Replacement Therapy Sales Growth
5 Americas
5.1 Americas Testosterone Replacement Therapy Sales by Country
5.1.1 Americas Testosterone Replacement Therapy Sales by Country (2020-2025)
5.1.2 Americas Testosterone Replacement Therapy Revenue by Country (2020-2025)
5.2 Americas Testosterone Replacement Therapy Sales by Type (2020-2025)
5.3 Americas Testosterone Replacement Therapy Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Testosterone Replacement Therapy Sales by Region
6.1.1 APAC Testosterone Replacement Therapy Sales by Region (2020-2025)
6.1.2 APAC Testosterone Replacement Therapy Revenue by Region (2020-2025)
6.2 APAC Testosterone Replacement Therapy Sales by Type (2020-2025)
6.3 APAC Testosterone Replacement Therapy Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Testosterone Replacement Therapy by Country
7.1.1 Europe Testosterone Replacement Therapy Sales by Country (2020-2025)
7.1.2 Europe Testosterone Replacement Therapy Revenue by Country (2020-2025)
7.2 Europe Testosterone Replacement Therapy Sales by Type (2020-2025)
7.3 Europe Testosterone Replacement Therapy Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Testosterone Replacement Therapy by Country
8.1.1 Middle East & Africa Testosterone Replacement Therapy Sales by Country (2020-2025)
8.1.2 Middle East & Africa Testosterone Replacement Therapy Revenue by Country (2020-2025)
8.2 Middle East & Africa Testosterone Replacement Therapy Sales by Type (2020-2025)
8.3 Middle East & Africa Testosterone Replacement Therapy Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Testosterone Replacement Therapy
10.3 Manufacturing Process Analysis of Testosterone Replacement Therapy
10.4 Industry Chain Structure of Testosterone Replacement Therapy
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Testosterone Replacement Therapy Distributors
11.3 Testosterone Replacement Therapy Customer
12 World Forecast Review for Testosterone Replacement Therapy by Geographic Region
12.1 Global Testosterone Replacement Therapy Market Size Forecast by Region
12.1.1 Global Testosterone Replacement Therapy Forecast by Region (2026-2031)
12.1.2 Global Testosterone Replacement Therapy Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Testosterone Replacement Therapy Forecast by Type (2026-2031)
12.7 Global Testosterone Replacement Therapy Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 AbbVie
13.1.1 AbbVie Company Information
13.1.2 AbbVie Testosterone Replacement Therapy Product Portfolios and Specifications
13.1.3 AbbVie Testosterone Replacement Therapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 AbbVie Main Business Overview
13.1.5 AbbVie Latest Developments
13.2 Endo International
13.2.1 Endo International Company Information
13.2.2 Endo International Testosterone Replacement Therapy Product Portfolios and Specifications
13.2.3 Endo International Testosterone Replacement Therapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Endo International Main Business Overview
13.2.5 Endo International Latest Developments
13.3 Eli lilly
13.3.1 Eli lilly Company Information
13.3.2 Eli lilly Testosterone Replacement Therapy Product Portfolios and Specifications
13.3.3 Eli lilly Testosterone Replacement Therapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Eli lilly Main Business Overview
13.3.5 Eli lilly Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Testosterone Replacement Therapy Product Portfolios and Specifications
13.4.3 Pfizer Testosterone Replacement Therapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Actavis (Allergan)
13.5.1 Actavis (Allergan) Company Information
13.5.2 Actavis (Allergan) Testosterone Replacement Therapy Product Portfolios and Specifications
13.5.3 Actavis (Allergan) Testosterone Replacement Therapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Actavis (Allergan) Main Business Overview
13.5.5 Actavis (Allergan) Latest Developments
13.6 Bayer
13.6.1 Bayer Company Information
13.6.2 Bayer Testosterone Replacement Therapy Product Portfolios and Specifications
13.6.3 Bayer Testosterone Replacement Therapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Bayer Main Business Overview
13.6.5 Bayer Latest Developments
13.7 Novartis
13.7.1 Novartis Company Information
13.7.2 Novartis Testosterone Replacement Therapy Product Portfolios and Specifications
13.7.3 Novartis Testosterone Replacement Therapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Novartis Main Business Overview
13.7.5 Novartis Latest Developments
13.8 Teva
13.8.1 Teva Company Information
13.8.2 Teva Testosterone Replacement Therapy Product Portfolios and Specifications
13.8.3 Teva Testosterone Replacement Therapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Teva Main Business Overview
13.8.5 Teva Latest Developments
13.9 Mylan
13.9.1 Mylan Company Information
13.9.2 Mylan Testosterone Replacement Therapy Product Portfolios and Specifications
13.9.3 Mylan Testosterone Replacement Therapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Mylan Main Business Overview
13.9.5 Mylan Latest Developments
13.10 Upsher-Smith
13.10.1 Upsher-Smith Company Information
13.10.2 Upsher-Smith Testosterone Replacement Therapy Product Portfolios and Specifications
13.10.3 Upsher-Smith Testosterone Replacement Therapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Upsher-Smith Main Business Overview
13.10.5 Upsher-Smith Latest Developments
13.11 Ferring Pharmaceuticals
13.11.1 Ferring Pharmaceuticals Company Information
13.11.2 Ferring Pharmaceuticals Testosterone Replacement Therapy Product Portfolios and Specifications
13.11.3 Ferring Pharmaceuticals Testosterone Replacement Therapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Ferring Pharmaceuticals Main Business Overview
13.11.5 Ferring Pharmaceuticals Latest Developments
13.12 Kyowa Kirin
13.12.1 Kyowa Kirin Company Information
13.12.2 Kyowa Kirin Testosterone Replacement Therapy Product Portfolios and Specifications
13.12.3 Kyowa Kirin Testosterone Replacement Therapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Kyowa Kirin Main Business Overview
13.12.5 Kyowa Kirin Latest Developments
13.13 Acerus Pharmaceuticals
13.13.1 Acerus Pharmaceuticals Company Information
13.13.2 Acerus Pharmaceuticals Testosterone Replacement Therapy Product Portfolios and Specifications
13.13.3 Acerus Pharmaceuticals Testosterone Replacement Therapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Acerus Pharmaceuticals Main Business Overview
13.13.5 Acerus Pharmaceuticals Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂